drug
FINTEPLA
updated 6mo agoby UCB SA
community read0 votes
🐶 often sniffed alongside
top 3all catalysts(0)
nothing on the calendar yet
Trials studying FINTEPLA
- phase3A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
- phase3A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome
- phase3An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
- phase3Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).
- phase3A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome
- —ZX008 Expanded Access Protocol
- phase3A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome
News(1)
- FDA dims Bright Minds’ outlook with partial hold on seizure trial over toxicity in miceThe FDA has put a partial hold on Bright Minds Biosciences’ seizure study application over preclinical toxicity data and concerns about its preparations for enrolling children.fiercebiotech · 15d ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that